Euroapi Company Header Euroapi Company Header

X

Find Cetilistat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Cetilistat
Also known as: 282526-98-1, Citilistat, Atl-962, 2-(hexadecyloxy)-6-methyl-4h-3,1-benzoxazin-4-one, Atl 962, 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one
Molecular Formula
C25H39NO3
Molecular Weight
401.6  g/mol
InChI Key
MVCQKIKWYUURMU-UHFFFAOYSA-N
FDA UNII
LC5G1JUA39

Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
1 2D Structure

Cetilistat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one
2.1.2 InChI
InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3
2.1.3 InChI Key
MVCQKIKWYUURMU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C=C2)C)C(=O)O1
2.2 Other Identifiers
2.2.1 UNII
LC5G1JUA39
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(hexadecyloxy)-6-methyl-4h-3,1-benzoxazin-4-one

2. Atl-962

2.3.2 Depositor-Supplied Synonyms

1. 282526-98-1

2. Citilistat

3. Atl-962

4. 2-(hexadecyloxy)-6-methyl-4h-3,1-benzoxazin-4-one

5. Atl 962

6. 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one

7. 4h-3,1-benzoxazin-4-one, 2-(hexadecyloxy)-6-methyl-

8. 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-one

9. Lc5g1jua39

10. 2-(hexadecyloxy)-6-methyl-4h-benzo[d][1,3]oxazin-4-one

11. Cetilistat [inn]

12. Oblean

13. Cametor

14. Unii-lc5g1jua39

15. Cetilistat (jan/usan/inn)

16. Atl962

17. Cetilistat [usan:inn:ban:jan]

18. Oblean (tn)

19. Cetilistat [mi]

20. Cetilistat [jan]

21. Cetilistat [usan]

22. Cetilistat [who-dd]

23. Schembl367612

24. Chembl2103825

25. Gtpl11433

26. Dtxsid90182506

27. Ex-a983

28. Chebi:134721

29. Hms3873m13

30. Act02675

31. Amy25231

32. Bcp07371

33. Ac-219

34. Mfcd09839697

35. S4930

36. Zinc14128264

37. Akos015915375

38. Ccg-268665

39. Cs-5623

40. Db06586

41. Ks-1251

42. Sb17399

43. Atl-962;atl962;atl 962

44. Ncgc00408859-01

45. Bc166233

46. Hy-14471

47. Ft-0657021

48. D09208

49. F16711

50. 526c981

51. A819389

52. Q3010545

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 401.6 g/mol
Molecular Formula C25H39NO3
XLogP39.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count16
Exact Mass401.29299411 g/mol
Monoisotopic Mass401.29299411 g/mol
Topological Polar Surface Area47.9 Ų
Heavy Atom Count29
Formal Charge0
Complexity477
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in obesity.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Obesity Agents

Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Lipid Regulating Agents

Substances that alter the metabolism of LIPIDS. (See all compounds classified as Lipid Regulating Agents.)


5.2 Mechanism of Action

Cetilistat is a gastrointestinal lipase inhibitor that blocks fat digestion and absorption, leading to reduced energy intake, and thus weight loss. It is distinct from most other anti-obesity agents as it does not act on the brain to reduce appetite, but acts peripherally. The compound remains in the gastrointestinal tract with no significant absorption into the body.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY